Anti-CLLD7

Item number	Size	Datasheet	Manual	SDS	Delivery time	Quantity	Price
ELK-ES6716.50	50 µl		-	-	10 - 14 business days*		173.00€
ELK-ES6716.100	100 µl		-	-	10 - 14 business days*		290.00€

If you have any questions, please use our Contact Form.
You can also order by e-mail: info@biomol.com
Larger quantity required? Request bulk

This gene encodes a protein with an N-terminal RCC1 domain and a C-terminal BTB (broad complex,... more

Close menu

Product information "Anti-CLLD7"

This gene encodes a protein with an N-terminal RCC1 domain and a C-terminal BTB (broad complex, tramtrack and bric-a-brac) domain. In rat, over-expression of this gene in vascular smooth muscle cells induced cellular hypertrophy. In rat, the C-terminus of RCBTB1 interacts with the angiotensin II receptor-1A. In humans, this gene maps to a region of chromosome 13q that is frequently deleted in B-cell chronic lymphocytic leukemia and other lymphoid malignancies. [provided by RefSeq, Jul 2008], Protein function: May be involved in cell cycle regulation by chromatin remodeling. [The UniProt Consortium] Recommended dilutions: Western Blot: 1/500 - 1/2000. Immunohistochemistry: 1/100 - 1/300. ELISA: 1/20000. Not yet tested in other applications.. Cellular localization: Nucleus .

Keywords:	Anti-CLLD7, Anti-RCBTB1, Anti-CLL deletion region gene 7 protein, Anti-RCC1 and BTB domain-containing protein 1, Anti-Chronic lymphocytic leukemia deletion region gene 7 protein, CLLD7 rabbit pAb
Supplier:	ELK Biotechnology
Supplier-Nr:	ES6716

Properties

Application:	WB, IHC, IF, ELISA
Antibody Type:	Polyclonal
Conjugate:	No
Host:	Rabbit
Species reactivity:	human, mouse
Immunogen:	The antiserum was produced against synthesized peptide derived from human RCBTB1. AA range:251-300
MW:	58 kD
Format:	Antiserum